Source: Investigational New Drugs. Unidade: ICB
Subjects: FARMACOLOGIA, ANTINEOPLÁSICOS, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS PANCREÁTICAS, COMPOSTOS AROMÁTICOS, CITOESQUELETO
ABNT
SILVA, Jean Carlos Lipreri da et al. NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells. Investigational New Drugs, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1007/s10637-022-01249-z. Acesso em: 30 ago. 2024.APA
Silva, J. C. L. da, Carvalho, M. F. L., Miranda, L. B. L. D., Almeida, B. O. de, Lima, K. C. de, & Machado Neto, J. A. (2022). NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells. Investigational New Drugs, 1-10. doi:10.1007/s10637-022-01249-zNLM
Silva JCL da, Carvalho MFL, Miranda LBLD, Almeida BO de, Lima KC de, Machado Neto JA. NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells [Internet]. Investigational New Drugs. 2022 ; 1-10.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1007/s10637-022-01249-zVancouver
Silva JCL da, Carvalho MFL, Miranda LBLD, Almeida BO de, Lima KC de, Machado Neto JA. NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells [Internet]. Investigational New Drugs. 2022 ; 1-10.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1007/s10637-022-01249-z